The five stories that made 2022 a pivotal year for life sciences IP
IAM looks back at the most important pharmaceuticals developments of the past 12 months
Source: iam-media.com
Page 13 - Genevant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Genevant Sciences Today - Breaking & Trending Today
Lipid Nanoparticles Market size is projected to grow US$ 3,175.5 Million by 2033
The global Lipid Nanoparticles Market size is expected to be valued at US$ 887.2 Million in 2023. With the increasing health concern among people for dietary supplements, in the light of Covid-19, coupled with the growing dietary supplement consumption, the overall demand for Lipid Nanoparticles is projected to grow...
Source: pharmiweb.com
Lawsuits on mRNA technology show profit-driven struggle for control over vital scientific discoveries
Recent lawsuits on mRNA technology are attempts by various corporations to take control of these vital discoveries for their own enrichment. Recent advances in molecular technology that allows for gene editing and protein manufacturing portend a revolution in medicine that can offer personalized treatments for a broad array of diseases.
Source: wsws.org
Arbutus Biopharma: Our Current Take On This 2 Buck 'Soap Opera' (NASDAQ:ABUS)
Arbutus Biopharma stock seems to be building a floor at current trading levels. Read more for a full investment analysis of ABUS stock.
Source: seekingalpha.com